Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
52 3. Quality Indicators<br />
<strong>Royal</strong> <strong>Devon</strong> <strong>and</strong> <strong>Exeter</strong> NHS Foundation Trust<br />
Quality <strong>Report</strong> <strong>2012</strong>/<strong>13</strong><br />
Indicator Group Indicator Description Data<br />
Monitor Indicators -<br />
Quality<br />
Monitor Indicators -<br />
Patient Experience<br />
Monitor Indicators -<br />
Patient Experience<br />
Monitor Indicators -<br />
Patient Experience<br />
Monitor Indicators -<br />
Quality<br />
Monitor Indicators -<br />
Quality<br />
Monitor Indicators -<br />
Quality<br />
Monitor Indicators -<br />
Quality<br />
Monitor Indicators -<br />
Patient Experience<br />
CQUIN Indicator<br />
All cancers: 62-day wait for first treatment<br />
from: NHS Cancer Screening Service referral<br />
Maximum time of 18 weeks from point of<br />
referral to treatment in aggregate – admitted<br />
Maximum time of 18 weeks from point of<br />
referral to treatment in aggregate – nonadmitted<br />
Maximum time of 18 weeks from point of<br />
referral to treatment in aggregate – patients<br />
on an incomplete pathway<br />
All cancers: 31-day wait from diagnosis to<br />
first treatment<br />
Cancer: two week wait from referral to date<br />
first seen comprising: all urgent referrals<br />
(cancer suspected)<br />
Cancer: two week wait from referral to date<br />
first seen comprising: for symptomatic breast<br />
patients (cancer not initially suspected)<br />
A&E: maximum waiting time of four hours<br />
from arrival to admission/transfer/discharge<br />
Certification against compliance with<br />
requirements regarding access to healthcare<br />
for people with a learning disability<br />
1. Venous Thrombo-embolism (VTE) Risk<br />
Assessment<br />
<strong>2012</strong>/<strong>13</strong> - 96.9%<br />
2011/12 - 93.8%<br />
2010/11 - 96.9%<br />
<strong>2012</strong>/<strong>13</strong> - 88.6%<br />
2011/12 - 93.6%<br />
2010/11 - 94.7%<br />
<strong>2012</strong>/<strong>13</strong> - 98.1%<br />
2011/12 - 97.8%<br />
2010/11 - 98.0%<br />
<strong>2012</strong>/<strong>13</strong> -91.9%<br />
2011/12 - 84.4% (no target)<br />
2010/11 - 86.5% (no target)<br />
<strong>2012</strong>/<strong>13</strong> - 96.3%<br />
2011/12 - 98.1%<br />
2010/11 - 97.3%<br />
<strong>2012</strong>/<strong>13</strong> - 95.5%<br />
2011/12 - 95.3%<br />
2010/11 - 97.8%<br />
<strong>2012</strong>/<strong>13</strong> - 96.5%<br />
2011/12 - 99.1%<br />
2010/11 - 98.4%<br />
<strong>2012</strong>/<strong>13</strong> - 96.2%<br />
2011/12 - 95.6%<br />
2010/11 - 97.9%<br />
<strong>2012</strong>/<strong>13</strong> - Compliant<br />
2011/12 - Compliant<br />
2010/11 - Compliant<br />
Q1 - 94.7% (Target 90%)<br />
Q2 - 94.7% (Target 90%)<br />
Q3 - 91.4% (Target 90%)<br />
Q4 - 94.6% (Target 90%)<br />
CQUIN Indicator 2. Patient Experience Q1 - N/A (Target N/A)<br />
Q2 - N/A (Target N/A)<br />
Q3 - N/A (Target N/A)<br />
Q4 - 73.3% (Target 73.5%)<br />
CQUIN Indicator 3a. Dementia Case Finding Q1 - Implementation Plan agreed between Trust <strong>and</strong> NHS<br />
<strong>Devon</strong> (Target Plan agreed)<br />
Q2 - Plan agreed (No target for Q2)<br />
Q3 - Plan agreed (No target for Q3)<br />
Q4 - 32% (Target 90%)<br />
CQUIN Indicator<br />
3b. Dementia Diagnostic Assessment <strong>and</strong><br />
Investigation<br />
Q1 - Implementation Plan agreed between Trust <strong>and</strong> NHS<br />
<strong>Devon</strong> (Target Plan agreed)<br />
Q2 - Plan agreed (No target for Q2)<br />
Q3 - Plan agreed (No target for Q3)<br />
Q4 - 40% (Target 90%)